Tag Archives: FDA

Five Things to Know: What the Election Results Mean for Healthcare Policy

Democrats’ slender majority in the House next year will have an outsized impact on healthcare policy and healthcare stakeholders in 2019 and beyond. From potential bipartisan deals on prescription drug prices to Democrats’ “shock and awe” oversight agenda, here are five things to know about what the 2018 midterm election results mean for healthcare policy … Continue Reading

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: The Senate will give the final OK to opioids legislation, HHS gets full-year funding for the first time in forever, new bipartisan legislation would allow FDA to update labels on older generic drugs, and … Continue Reading

Senate OKs Opioids Response Bill as Lawmakers Scramble to Pass Final Measure

The Senate this week overwhelmingly approved legislation to address the opioid crisis, and now Congress is racing to cobble together a final measure that could pass before the midterm elections in November. The Senate-passed legislation is sweeping in scope: It is composed of more than 70 individual bills approved by five committees. Packaged together, this legislation … Continue Reading
LexBlog